FindTrial
Sign In

Lipid apheresis

OTHER3 trials

Sponsors

Charite University, Berlin, Germany, Karl Winkler, Faculty of Medicine Siriraj Hospital, Mahidol University

Conditions

DyslipidemiaHyperlipoproteinemia(a)HypertensionPreeclampsiaProgressive Cardiovascular DiseaseProteinuriahyperlipoprotein(a) Hyperlipoprotein(a) Lipid apheresis lipoprotein(a)

Phase 2

The efficacy of lipoprotein(a) removal by lipoprotein apheresis in patients with hyperlipoprotein(a)
Active, not recruitingTCTR20260708005
Faculty of Medicine Siriraj Hospital, Mahidol Universityhyperlipoprotein(a) Hyperlipoprotein(a) Lipid apheresis lipoprotein(a)
Start: 2026-08-01Target: 5Updated: 2026-08-03

Unknown Phase

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)
WithdrawnNCT01064934
Charite University, Berlin, GermanyHyperlipoproteinemia(a), Progressive Cardiovascular Disease
Start: 2010-09-30End: 2015-08-31Updated: 2015-06-04
Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis
CompletedNCT01967355
Karl WinklerDyslipidemia, Hypertension, Preeclampsia +1
Start: 2013-04-30End: 2014-05-08Updated: 2018-08-09

Related Papers

Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia
Pregnancy Hypertension2024-05-094 citations
Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study.
2018-04-1117 citations
Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study.
2018-03-1412 citations